Introducing Univation Labs, a cooperative effort of Oswald Companies and PeopleOne Health designed to bring purposeful, positive disruption to the insurance sector through innovation, collaboration and experimentation. Combining the unparalleled insurance experience of Oswald with the proven, world class technology and human-centric healthcare approach of PeopleOne Health, Univation Labs promises to deliver leading edge solutions to clients and partners. From internally developing new resources to seeking out and vetting leaders in the arena, this new paradigm will be a catalyst for creating the next generation of employer healthcare.

How will Univation Labs do this? By fostering the collaboration of industry experts, academics and clinicians within our Clinical Advisory Board, and allowing those thought leaders to interface with leading technologists, data experts, and innovation evangelists. This unique approach will create an environment focused on experimentation, communication, transparency, rapid prototyping, and seamless implementation - increasing delivery of viable and dynamic offerings to the marketplace.

“Univation Labs combines the start-up incubator mindset, proven world-class technology and the unparalleled industry expertise of Oswald. This is an amazing opportunity to bring a higher level of product and service innovation to bear for current and future clients,” said Jordan Taradash, CEO of PeopleOne Health. “This partnership will drive true change, and revolutionize the industry for both employers and their workforces.”

Key features include:

• An incubator to relentlessly and purposefully experiment
• Accelerate speed from idea to implementation
• Human-centric focus to shift thinking

“Oswald is always on the forefront of market-leading innovations and excited to take this next step with PeopleOne Health,” said John Fasola, Senior Vice President, Director of Employee Benefits at Oswald Companies. “We look forward to expanding upon our partnerships and bringing superior solutions to our clients.”